Utility of laboratory and immune biomarkers in predicting disease progression and mortality among patients with moderate to severe COVID-19 disease at a Philippine tertiary hospital
Punzalan, Felix Eduardo R, Aherrera, Jaime Alfonso M, de Paz-Silava, Sheriah Laine M, Mondragon, Alric V, Malundo, Anna Flor G, Tan, Joanne Jennifer E, Tantengco, Ourlad Alzeus G, Quebral, Elgin Paul B, Uy, Mary Nadine Alessandra R, Lintao, Ryan C V, Dela Rosa, Jared Gabriel L, Mercado, Maria Elizabeth P, Avenilla, Krisha Camille, Poblete, Jonnel B, Albay, Jr, Albert B, David-Wang, Aileen S, Alejandria, Marissa M
Published in Frontiers in immunology (28.02.2023)
Published in Frontiers in immunology (28.02.2023)
Get full text
Journal Article
Intravenous Tocilizumab versus Standard of Care in the Treatment of Severe and Critical COVID-19-related Pneumonia: A Single-center, Double-blind, Placebo-controlled, Phase 3 Trial
Amante, Eric Jason B, David-Wang, Aileen S, Tee, Michael L, Punzalan, Felix Eduardo R, Añonuevo, John C, Fernandez, Lenora C, Albay, Jr, Albert B, Malabad, John Carlo M, Climacosa, Fresthel Monica M, Pajes, A Nico Nahar I, Cuaño, Patricia Maria Gregoria M, Alejandría, Marissa M
Published in Acta medica Philippina (2024)
Published in Acta medica Philippina (2024)
Get full text
Journal Article
A rapid monoclonal antibody blood theophylline assay; lack of cross-reactivity with enprofylline
David-Wang, A S, Scarth, B, Freeman, D, Chapman, K R
Published in Therapeutic drug monitoring (01.06.1994)
Published in Therapeutic drug monitoring (01.06.1994)
Get more information
Journal Article